APA (7th ed.) Citation

Hegde, A., Vasdev, V., Shanmuganandan, K., Singh, K., Kartik, S., & Kumar, A. Safety and efficacy of an Anti-CD20 Monoclonal antibody (RedituxTM) In Indian patients with seropositive rheumatoid arthritis. SAGE Publishing.

Chicago Style (17th ed.) Citation

Hegde, Arun, Vivek Vasdev, Krishnan Shanmuganandan, Kavita Singh, Sivasami Kartik, and Abhishek Kumar. Safety and Efficacy of an Anti-CD20 Monoclonal Antibody (RedituxTM) In Indian Patients with Seropositive Rheumatoid Arthritis. SAGE Publishing.

MLA (9th ed.) Citation

Hegde, Arun, et al. Safety and Efficacy of an Anti-CD20 Monoclonal Antibody (RedituxTM) In Indian Patients with Seropositive Rheumatoid Arthritis. SAGE Publishing.